Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Ploussard

Showing results (1-10 of 410) with videos related to

Pageof 41
Sort By:
La Revue Du Praticien|May 21, 2013
[Active surveillance for low-risk prostate cancer]Guillaume Ploussard
European Urology Focus|July 20, 2017
Kallikreins Panel for Prostate Cancer Aggressiveness Prediction: More Is Not EnoughGuillaume Ploussard
The Journal of Urology|December 3, 2013
Editorial commentGuillaume Ploussard
The Journal of Urology|September 22, 2012
How much should we pursue an elevated prostate specific antigen?Guillaume Ploussard
European Urology|July 7, 2020
Re: Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multi-centre StudyGuillaume Ploussard
Current Opinion in Urology|December 13, 2017
Robotic surgery in urology: facts and reality. What are the real advantages of robotic approaches for prostate cancer patients?Guillaume Ploussard
European Urology|November 16, 2019
Re: Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate CancerGuillaume Ploussard
European Urology|October 17, 2017
Re: Salvage High-intensity Focused Ultrasound (HIFU) for Locally Recurrent Prostate Cancer After Failed Radiation Therapy: Multi-institutional Analysis of 418 PatientsGuillaume Ploussard
European Urology Oncology|May 23, 2025
Reply to Isabel Heidegger and Jasmin Bektic's Letter to the Editor re: Michael Baboudjian, Riccardo Leni, Marco Oderda, et al., Active Surveillance of Grade Group 2 Prostate Cancer: Oncological Outcomes from a Contemporary European Cohort. Eur Urol Oncol. 2025;8:1257-1263Michael Baboudjian, Guillaume Ploussard
Prostate Cancer and Prostatic Diseases|February 13, 2023
Reply to: Fact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biopsy to prostatectomy specimenAlberto Martini, Guillaume Ploussard
Pageof 41

Showing results (1-10 of 410) with videos related to

Sort By:
Pageof 41
La Revue Du Praticien|May 21, 2013
[Active surveillance for low-risk prostate cancer]Guillaume Ploussard
European Urology Focus|July 20, 2017
Kallikreins Panel for Prostate Cancer Aggressiveness Prediction: More Is Not EnoughGuillaume Ploussard
The Journal of Urology|December 3, 2013
Editorial commentGuillaume Ploussard
The Journal of Urology|September 22, 2012
How much should we pursue an elevated prostate specific antigen?Guillaume Ploussard
European Urology|July 7, 2020
Re: Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multi-centre StudyGuillaume Ploussard
Current Opinion in Urology|December 13, 2017
Robotic surgery in urology: facts and reality. What are the real advantages of robotic approaches for prostate cancer patients?Guillaume Ploussard
European Urology|November 16, 2019
Re: Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate CancerGuillaume Ploussard
European Urology|October 17, 2017
Re: Salvage High-intensity Focused Ultrasound (HIFU) for Locally Recurrent Prostate Cancer After Failed Radiation Therapy: Multi-institutional Analysis of 418 PatientsGuillaume Ploussard
European Urology Oncology|May 23, 2025
Reply to Isabel Heidegger and Jasmin Bektic's Letter to the Editor re: Michael Baboudjian, Riccardo Leni, Marco Oderda, et al., Active Surveillance of Grade Group 2 Prostate Cancer: Oncological Outcomes from a Contemporary European Cohort. Eur Urol Oncol. 2025;8:1257-1263Michael Baboudjian, Guillaume Ploussard
Prostate Cancer and Prostatic Diseases|February 13, 2023
Reply to: Fact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biopsy to prostatectomy specimenAlberto Martini, Guillaume Ploussard
Pageof 41